Normal-Weight Obesity: When BMI Hides Risk

By Longevity Lab · Published: August 23, 2026

Based on peer-reviewed research — full source list at the end of this article. This is educational information, not medical advice.

Normal-weight obesity is a body mass index inside the healthy band — 18.5 to 24.9 — combined with a body fat percentage high enough to carry the metabolic consequences of obesity. It is invisible to BMI by construction, because the index measures mass and this condition is about composition. In cohort studies the pattern is associated with insulin resistance, adverse lipids and higher cardiovascular mortality than the index would ever predict, and the people it describes are usually told their weight is fine.

What the condition actually is

Two people can weigh 62 kg at 1.68 m — a BMI of 22.0 — and differ by 12 kg in fat mass. One carries 24% body fat and a reasonable amount of muscle; the other carries 36% body fat and very little. The index reports 22.0 for both.

When the excess fat is stored inside the abdomen rather than under the skin, the phenotype is often called TOFI — normal-weight obesity: thin outside, fat inside. Imaging studies have found substantial visceral and liver fat in people whose external appearance and BMI are entirely unremarkable, which is how the term arose.

The mechanism is not mysterious. Visceral adipose tissue is metabolically active, secretes inflammatory cytokines, and delivers free fatty acids directly to the liver through the portal vein. It does that whether or not the person carrying it weighs a lot.

What the outcomes look like

Analyses of NHANES participants found that adults in the highest sex-specific body fat tertile with a normal BMI had a markedly higher prevalence of metabolic syndrome than normal-BMI adults with low body fat, and elevated cardiovascular mortality on follow-up — in women, higher than in some overweight groups.

The reason it matters clinically is the screening gap. Someone with a BMI of 33 will be offered a glucose test and a lipid panel almost anywhere. Someone with a BMI of 22 and 34% body fat will not, because nothing in the routine pathway looks at composition. The risk is comparable and the detection is not.

The concept is old. It was described in 1998 as the “metabolically obese, normal-weight” individual — normal body weight with hyperinsulinemia, insulin resistance and a predisposition to type 2 diabetes and cardiovascular disease. Nearly three decades later, BMI-only screening still misses it.

How to detect it without a scan

1. Waist-to-height ratio. Above 0.5 with a BMI under 25 is the classic signature. This is the single most useful check, and it is free.
2. Waist circumference. Above 94 cm in men or 80 cm in women, at a normal BMI, means the same thing.
3. A fasting blood panel. Triglycerides, HDL, fasting glucose and, if available, fasting insulin. Insulin resistance is the mechanism, and it shows up in these numbers before anything else does.
4. A body fat estimate. Above roughly 25% in men or 35% in women at a normal BMI confirms the picture.

Body fat assessment estimates the fat fraction from tape measurements, which avoids the hydration sensitivity of home impedance scales. If you already have a fasting panel, METS-IR: metabolic score for insulin resistance combines glucose, triglycerides, HDL and BMI into a score that tracks insulin resistance directly — and it is precisely in the normal-BMI case that it adds information the index cannot.

Who tends to have it

Four groups come up repeatedly. Adults over 50, in whom muscle loss and central fat gain offset each other on the scale. People of South and East Asian descent, who accumulate visceral fat at a lower body weight — the reason WHO recommends lower BMI action points for those populations. People who have lost significant weight through caloric restriction alone, without resistance training, and regained fat but not muscle. And people who are sedentary but genuinely eat little — low weight is not evidence of a favorable composition.

None of these are exotic. Together they account for a large fraction of adults with a reassuring BMI.

What to do about it

The intervention is not weight loss, because there is little weight to lose. It is composition change: build muscle and reduce visceral fat, which often leaves the scale exactly where it was.

Resistance training two to three times a week is the primary lever, because it is the only one that reliably adds lean mass. Adequate protein — roughly 1.2 to 1.6 g per kilogram of body weight for adults trying to build or preserve muscle — supports it. Aerobic exercise reduces visceral fat specifically, and it does so at doses that do not produce weight loss. Reducing refined carbohydrate and alcohol targets liver fat, which travels with the visceral compartment.

Track waist and strength rather than weight. If BMI does not move while waist falls and lifts improve, the intervention is working exactly as intended — and the number that started this whole article will keep saying nothing.

Frequently asked questions

Sources

Disclaimer. This article is for information only and does not replace medical advice. Talk to a qualified clinician before changing anything about your health.